177 related articles for article (PubMed ID: 6201685)
1. 5-aza-2'-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation.
Momparler RL; Bouchard J; Onetto N; Rivard GE
Leuk Res; 1984; 8(2):181-5. PubMed ID: 6201685
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2'-deoxycytidine as a possible mechanism of chemotherapeutic action.
Wilson VL; Jones PA; Momparler RL
Cancer Res; 1983 Aug; 43(8):3493-6. PubMed ID: 6190553
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.
Momparler RL; Côté S; Eliopoulos N
Leukemia; 1997 Feb; 11(2):175-80. PubMed ID: 9009076
[TBL] [Abstract][Full Text] [Related]
4. Induction of differentiation and inhibition of DNA methylation in HL-60 myeloid leukemic cells by 5-AZA-2'-deoxycytidine.
Momparler RL; Bouchard J; Samson J
Leuk Res; 1985; 9(11):1361-6. PubMed ID: 2417065
[TBL] [Abstract][Full Text] [Related]
5. Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells.
Bhalla K; Cole J; MacLaughlin W; Arlin Z; Baker M; Graham G; Grant S
Leukemia; 1987 Dec; 1(12):814-9. PubMed ID: 2447450
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of 5-Aza-2'-deoxycytidine and genistein in combination against leukemia.
Raynal NJ; Charbonneau M; Momparler LF; Momparler RL
Oncol Res; 2008; 17(5):223-30. PubMed ID: 18980019
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antineoplastic activity of cytosine arabinoside and 5-aza-2'-deoxycytidine against human leukemic cells of different phenotype.
Momparler RL; Onetto-Pothier N; Momparler LF
Leuk Res; 1990; 14(9):755-60. PubMed ID: 1700231
[TBL] [Abstract][Full Text] [Related]
8. Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cells.
Chabot GG; Momparler RL
Leuk Res; 1986; 10(5):533-7. PubMed ID: 2423812
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.
Momparler RL; Côté S; Eliopoulos N
Leukemia; 1997 Mar; 11 Suppl 1():S1-6. PubMed ID: 9130684
[TBL] [Abstract][Full Text] [Related]
10. Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidine.
Thottassery JV; Sambandam V; Allan PW; Maddry JA; Maxuitenko YY; Tiwari K; Hollingshead M; Parker WB
Cancer Chemother Pharmacol; 2014 Aug; 74(2):291-302. PubMed ID: 24908436
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia.
Lemaire M; Momparler LF; Bernstein ML; Marquez VE; Momparler RL
Anticancer Drugs; 2005 Mar; 16(3):301-8. PubMed ID: 15711182
[TBL] [Abstract][Full Text] [Related]
12. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
Kong XB; Tong WP; Chou TC
Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001
[TBL] [Abstract][Full Text] [Related]
13. Induction of cytidine deaminase in HL-60 myeloid leukemic cells by 5-aza-2'-deoxycytidine.
Momparler RL; Laliberté J
Leuk Res; 1990; 14(9):751-4. PubMed ID: 1700230
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by phenylbutyrate on L1210 leukemic cells.
Lemaire M; Momparler LF; Farinha NJ; Bernstein M; Momparler RL
Leuk Lymphoma; 2004 Jan; 45(1):147-54. PubMed ID: 15061212
[TBL] [Abstract][Full Text] [Related]
15. In vitro biochemical tests to evaluate the response to therapy of acute leukemia with cytosine arabinoside or 5-AZA-2'-deoxycytidine.
Onetto N; Momparler RL; Momparler LF; Gyger M
Semin Oncol; 1987 Jun; 14(2 Suppl 1):231-7. PubMed ID: 2438776
[No Abstract] [Full Text] [Related]
16. DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture.
Kautiainen TL; Jones PA
J Biol Chem; 1986 Feb; 261(4):1594-8. PubMed ID: 2418016
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.
Momparler RL; Momparler LF
Cancer Chemother Pharmacol; 1989; 25(1):51-4. PubMed ID: 2480188
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effects and DNA hypomethylation by 5-aza-2'-deoxycytidine in human neuroblastoma cell lines.
Carpinelli P; Granata F; Augusti-Tocco G; Rossi M; Bartolucci S
Anticancer Drugs; 1993 Dec; 4(6):629-35. PubMed ID: 7507741
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial on 5-aza-2'-deoxycytidine in patients with acute leukemia.
Momparler RL; Rivard GE; Gyger M
Pharmacol Ther; 1985; 30(3):277-86. PubMed ID: 2433702
[No Abstract] [Full Text] [Related]
20. Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.
Fabiani E; Leone G; Giachelia M; D'alo' F; Greco M; Criscuolo M; Guidi F; Rutella S; Hohaus S; Voso MT
Leuk Lymphoma; 2010 Dec; 51(12):2275-84. PubMed ID: 21077739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
